ethyl pyruvate has been researched along with Pulmonary Arterial Remodeling in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, G; Dou, Y; Feng, D; Li, H; Liu, C; Shen, H; Sun, L; Sun, Q; Tian, X; Wang, Z; Zhou, F | 1 |
Cao, G; Liu, C; Liu, K; Liu, Y; Pang, X; Sun, H; Zhang, X | 1 |
Ding, X; Jiang, J; Liu, Y; Su, Q; Zhou, C | 1 |
3 other study(ies) available for ethyl pyruvate and Pulmonary Arterial Remodeling
Article | Year |
---|---|
HMGB1 promotes neurovascular remodeling via Rage in the late phase of subarachnoid hemorrhage.
Topics: Animals; Benzamides; Brain; Brain Injuries; Cerebral Cortex; Disease Models, Animal; Doublecortin Protein; Glycyrrhizic Acid; HMGB1 Protein; Male; Neurons; Pyruvates; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Recombinant Proteins; Signal Transduction; Subarachnoid Hemorrhage; Vascular Remodeling | 2017 |
Intratracheal instillation of ethyl pyruvate nanoparticles prevents the development of shunt-flow-induced pulmonary arterial hypertension in a rat model.
Topics: Animals; Disease Models, Animal; Endothelin-1; Hypertension, Pulmonary; Interleukin-6; Lung; Male; Nanoparticles; Polyesters; Polyethylene Glycols; Protective Agents; Pulmonary Artery; Pyruvates; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Vascular Remodeling | 2016 |
Blockade of HMGB1 preserves vascular homeostasis and improves blood perfusion in rats of acute limb ischemia/reperfusion.
Topics: Actins; Animals; Anti-Inflammatory Agents; Blood Flow Velocity; Disease Models, Animal; Hemorheology; Heparin; Hindlimb; HMGB1 Protein; Inflammation Mediators; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Muscle, Skeletal; Pyruvates; Rats, Wistar; Recovery of Function; Regional Blood Flow; Reperfusion Injury; Signal Transduction; Vascular Remodeling | 2017 |